ARCHIVES

EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure.

This article is from The Cancer Letter archive.

Vol. 33 No. 08 | March 2, 2007

Download PDF Visit The Full Archive

Related Articles

Simmonds Succeeds Young As ACS President; Lame-Duck Session Unlikely To Approve Funding Bills

November 8, 2002

Copyright Violation Of Cancer Letter – Results In Payment

July 19, 1991

In Brief: St. Jude To Stay In Memphis; Katterhagens Move To Illinois; ACCC, Nixon In DC Next Week

March 28, 1986

In Brief: Li, Gart Retire Forom NCI; Clifford Heads Diet Branch; ASTRO Meeting Nov. 4-8 In Washington

October 18, 1991

In Brief: Jordan To Join MD Anderson Cancer Center

July 25, 2014

In Brief: St. Jude, Yale to Get Bristol-Myers Grants; Five Named for New Young Scientists Awards

May 6, 1988